TRUDY LOVEJOY: Open Payments
NPI 1255589313 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,453 in 169 payments from 35 companies in 2025. Trend: 2023 $2,012 · 2024 $2,155 · 2025 $3,453
Food & beverage: $3,303Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $499 |
| Novartis Pharmaceuticals Corporation | 10 | $250 |
| ACADIA Pharmaceuticals Inc | 10 | $239 |
| CSL Behring | 5 | $223 |
| Teva Pharmaceuticals USA, Inc. | 12 | $199 |
| Neurocrine BioSciences, Inc. | 8 | $163 |
| Lundbeck LLC | 8 | $162 |
| Biogen, Inc. | 1 | $150 |
| Axsome Therapeutics, Inc. | 12 | $135 |
| TG Therapeutics, Inc. | 5 | $113 |
Products named: KESIMPTA, NUPLAZID, UBRELVY, Hizentra, AUSTEDO XR, INGREZZA, TYSABRI, VYEPTI.
Industry payments across SC — which companies pay providers there.
